These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9929705)

  • 1. Advances in the etiology and treatment of venous thromboembolism.
    Comp PC
    Adv Intern Med; 1999; 44():59-89. PubMed ID: 9929705
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiology patient page. Factor V Leiden.
    Ornstein DL; Cushman M
    Circulation; 2003 Apr; 107(15):e94-7. PubMed ID: 12707252
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombophilias associated with cerebral venous thrombosis].
    Schlück E; Rodier G; Derouiche F; Bronner P; Boulay C; Courtois S; Cohen E
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):543-52. PubMed ID: 12072822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent thrombembolic risk in patients with multiple thrombophilic disorders.
    Agoşton-Coldea L; Rusu LD; Bobar C; Rusu ML; Mocan T; Procopciuc LM
    Rom J Intern Med; 2008; 46(3):261-6. PubMed ID: 19366087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis: new culprits in an old disorder.
    Federman DG; Moriarty JP; Kravetz JD; Kirsner RS
    Panminerva Med; 2002 Jun; 44(2):107-13. PubMed ID: 12032428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy-related recurrent events in thrombophilic women with previous venous thromboembolism.
    Simioni P; Tormene D; Prandoni P; Girolami A
    Thromb Haemost; 2001 Sep; 86(3):929. PubMed ID: 11583329
    [No Abstract]   [Full Text] [Related]  

  • 9. The vascular adverse events of protein S deficiency: a case report.
    Mayo D; Zavada MC; Southerland CC
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):209-12. PubMed ID: 21746800
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
    Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
    Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potential role of primary hypercoagulability and antiphospholipid antibody as a risk factor of acute pulmonary thromboembolism].
    Tokuyama K; Kiuchi K; Nejima J; Takayama M; Takano T; Hayakawa H
    J Cardiol; 1998 Oct; 32(4):263-8. PubMed ID: 9833233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 13. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
    De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
    Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk factors of venous thrombosis.
    Franco RF; Reitsma PH
    Hum Genet; 2001 Oct; 109(4):369-84. PubMed ID: 11702218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
    Rossi E; Za T; Ciminello A; Leone G; De Stefano V
    Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of thrombotic children with malignancy.
    Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
    Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic risk factors of venous thromboembolism].
    Oner F; Kaya A; Doğan R; Numanoğlu N
    Tuberk Toraks; 2003; 51(1):60-9. PubMed ID: 15100907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
    Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
    Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden with deep venous thrombosis.
    Gardner J
    Clin Lab Sci; 2003; 16(1):6-9. PubMed ID: 12587652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.